US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist

22.970
+0.390+1.73%

Close Mar 11 16:00 ET

22.970
0.0000.00%

Post 16:05 ET

631.70MMarket Cap-5.47P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LENZ Therapeutics Q4 2024 Estimates Date

Currency：USDMar 19, 2025

	Estimate	YoY
Revenue	0	--
EPS	-0.41	--

Analyst Rating

Buy

Feb 28, 2025

LENZ Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
Mar 19, 2025	2024/Q4	-- / 0.000	--
Nov 6, 2024	2024/Q3	0.000 / 0.000	--
Aug 14, 2024	2024/Q2	0.000 / 0.000	--
May 8, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

Mar 19, 20252024/Q4-- / 0.000--

Nov 6, 20242024/Q30.000 / 0.000--

Aug 14, 20242024/Q20.000 / 0.000--

May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

LENZ Therapeutics Earnings Reports

LENZ Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 20:37

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Third Quarter 2024 Financial Results

Nov 6, 2024 20:27

LENZ Therapeutics | 10-Q: Quarterly report

Aug 15, 2024 04:21

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 15, 2024 04:10